If not the world’s leading gene therapy research center, Nationwide Children’s Hospital seeks to aggressively expand into gene therapy research with the launch of a $74 million biotechnology manufacturing facility for genetic material used in research and clinical...
Nationwide Children’s Hospital
Category
Nationwide Children’s Hospital to Spinout Andelyn Biosciences to Lead Commercialization of Gene Therapy Services
Nationwide Children’s Hospital, a national center of excellence in gene therapy, will spinoff Andelyn Biosciences, a new for-profit venture to manufacture gene therapy products for biopharmaceutical clinical sponsors. Gene Therapy Future TrialSite News has discussed...
Nationwide Children’s Hospital, Columbus: The Nexus of the Nation’s Gene Therapy Research Boom
Ben Fidler writing for Xconomy reports that Nationwide Children’s Hospital has signed nearly 30 gene therapy biotech deals since 2018—this includes licensing deals as well as outright spin offs. Nationwide has become a national gene therapy leader thanks to...